The Patent Finder

Terms ending in 2029

Ucb Pharma S.A.

Every in-force patent on Ucb Pharma S.A.'s record whose computed term ends in 2029, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 8,183,2412-OXO-1-Pyrrolidine Derivatives
In force
 · Medium confidence
Ucb Biopharma SRLIn forceMedium confidence
US 8,242,116Fused Thiazole Derivatives as Kinase Inhibitors
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 8,293,237Binding Proteins, Including Antibodies, Antibody Derivatives and Antibody Fragments, That Specifically Bind CD154 and Uses Thereof
In force
 · High confidence
Ucb Biopharma SRLIn forceHigh confidence
US 8,501,723Pharmaceutical Compositions Comprising Fesoterodine
In force
 · Medium confidence
Ucb Pharma GmbHIn forceMedium confidence
US 8,075,889Antibody Molecules Having Specificity for Human IL-6
In force
 · High confidence
R-Pharm International LLCIn forceHigh confidence
US D724,203Drive Device for Administering Medication
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US D726,901Drive Device for Administering Medication
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US D726,902Cassette Device for Administering Medication
In force
 · High confidence
Ucb Biopharma SPRLIn forceHigh confidence
US 8,679,494Antibodies Specific to IL-17A and IL-17F
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
US 9,771,420Methods of Treating an IL-17A Mediated Pathological Condition
In force
 · Medium confidence
Ucb Biopharma SPRLIn forceMedium confidence
6 more term ends in 2029 · Pro
10 of 16 patents shown. Soonest term end first, then patent number.
Pro members see all 16.
Upgrade to Pro
2 of these are in force and held by Ucb Pharma S.A..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited